Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Jan-24 7:07 PM View:  | Acumen Pharmaceuticals, Inc. (ABOS) | 19-Jan-24 | Sale (Planned) | 15,200 | $3.47 | $52,753.10 | (3%) 517.68K to 502.49K | |
| 04-Jan-24 4:18 PM View: | Acumen Pharmaceuticals, Inc. (ABOS) | 02-Jan-24 | Grant | 401,000 | -- | -- | 344% 116.69K to 517.68K | |
| 18-Jan-23 4:22 PM View: | Acumen Pharmaceuticals, Inc. (ABOS) | 17-Jan-23 | Grant | 114,000 | -- | -- | 4246% 2.69K to 116.69K | |
| 02-Dec-21 4:41 PM View: | Acumen Pharmaceuticals, Inc. (ABOS) | 30-Nov-21 | Option Exercise | 1,118 | $4.47 | $4,997.46 | 71% 1.57K to 2.69K | |
| 08-Jul-21 6:16 PM View: | Acumen Pharmaceuticals, Inc. (ABOS) | 06-Jul-21 | Conversion | 123 | -- | -- | 9% 1.42K to 1.54K | |
| 08-Jul-21 6:16 PM View: | Acumen Pharmaceuticals, Inc. (ABOS) | 06-Jul-21 | Payment of Exercise | 10 | $16.00 | $160.00 | (< 1%) 1.58K to 1.57K | |
| 08-Jul-21 6:16 PM View: | Acumen Pharmaceuticals, Inc. (ABOS) | 06-Jul-21 | Exercise (in-the money or at-the-money) | 35 | $4.47 | $156.45 | 2% 1.54K to 1.58K |